Gene Gene synonym Ensembl Gene description Chromosome Position Protein class Evidence summary HPA evidence UniProt evidence MS evidence Antibody Reliability (IH) Reliability (Mouse Brain) Reliability (IF) Subcellular location RNA tissue category RNA TS RNA TS FPKM FPKM max in non-specific CACNA1A APCA, CACNL1A4, Cav2.1, EA2, FHM, HPCA, MHP, MHP1, SCA6 ENSG00000141837 Calcium channel, voltage-dependent, P/Q type, alpha 1A subunit 19 13206442-13623990 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA064258 Supportive Uncertain Golgi apparatus, Vesicles, Nucleus but not nucleoli Tissue enhanced 0 cerebral cortex: 7.9;stomach: 4.9 adrenal gland: 1.5 CACNA1B CACNL1A5, CACNN, Cav2.2 ENSG00000148408 Calcium channel, voltage-dependent, N type, alpha 1B subunit 9 137877789-138124624 FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA044347 Uncertain Group enriched 12 adrenal gland: 2.1;cerebral cortex: 6.3;fallopian tube: 2.4;testis: 3.3 prostate: 0.3 CACNA1C CACH2, CACN2, CACNL1A1, Cav1.2, CCHL1A1, LQT8, TS ENSG00000151067 Calcium channel, voltage-dependent, L type, alpha 1C subunit 12 1970786-2697950 Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA039796 Supportive Tissue enhanced 0 heart muscle: 17.7;smooth muscle: 17.2 endometrium: 12.7 CACNA1D CACH3, CACN4, CACNL1A2, Cav1.3, CCHL1A2 ENSG00000157388 Calcium channel, voltage-dependent, L type, alpha 1D subunit 3 53494656-53813733 Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level HPA020215 Uncertain Tissue enhanced 0 fallopian tube: 8.2 adrenal gland: 6.7 CACNA1E BII, CACH6, CACNL1A6, Cav2.3 ENSG00000198216 Calcium channel, voltage-dependent, R type, alpha 1E subunit 1 181413102-181808084 Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enriched 7 cerebral cortex: 5.1 adrenal gland: 0.7 CACNA1F AIED, Cav1.4, CORDX3, CSNB2, CSNB2A, CSNBX2, JM8, JMC8, OA2 ENSG00000102001 Calcium channel, voltage-dependent, L type, alpha 1F subunit X 49205063-49233371 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Mixed small intestine: 0.7 CACNA1G Cav3.1, NBR13 ENSG00000006283 Calcium channel, voltage-dependent, T type, alpha 1G subunit 17 50561068-50627474 FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA004714 Uncertain Uncertain Nucleus but not nucleoli, Cytoplasm Tissue enhanced 0 cerebral cortex: 4.5;endometrium: 2.4 fallopian tube: 2.1 CACNA1H Cav3.2 ENSG00000196557 Calcium channel, voltage-dependent, T type, alpha 1H subunit 16 1153241-1221771 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level HPA039125 Uncertain Tissue enhanced 0 ovary: 31.3 prostate: 16.3 CACNA1I Cav3.3 ENSG00000100346 Calcium channel, voltage-dependent, T type, alpha 1I subunit 22 39570753-39689737 FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 cerebral cortex: 2.2 lymph node: 1.4 CACNA1S CACNL1A3, Cav1.1, HOKPP, hypoPP, MHS5 ENSG00000081248 Calcium channel, voltage-dependent, L type, alpha 1S subunit 1 201039512-201112566 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB009507, HPA048892, HPA056815 Supportive Tissue enriched 31 skeletal muscle: 76.8 esophagus: 2.4 CATSPER2 ENSG00000166762 Cation channel, sperm associated 2 15 43628503-43668118 Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level HPA042709 Uncertain Uncertain Plasma membrane, Mitochondria, Cytoplasm Tissue enhanced 0 testis: 8.8 thyroid gland: 2.0 CATSPER4 ENSG00000188782 Cation channel, sperm associated 4 1 26190561-26202968 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level HPA045257 Supportive Tissue enriched 49 testis: 4.8 adipose tissue: 0.0 CNGA1 CNCG, CNCG1, CNG1, RCNC1, RCNCa, RP49 ENSG00000198515 Cyclic nucleotide gated channel alpha 1 4 47935977-48016672 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA059734 Uncertain Nucleus, Nucleoli, Plasma membrane, Cytoplasm Mixed liver: 6.6 CNGA2 CNCA, CNCA1, CNG2, FLJ46312, OCNC1, OCNCa, OCNCALPHA ENSG00000183862 Cyclic nucleotide gated channel alpha 2 X 151738451-151745304 Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level No evidence Evidence at transcript level Evidence at protein level HPA015065 Uncertain Not detected testis: 0.2 CNGA3 ACHM2, CCNC1, CCNCa, CNCG3, CNG3 ENSG00000144191 Cyclic nucleotide gated channel alpha 3 2 98346155-98398601 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Mixed esophagus: 1.3 CNGA4 CNCA2, CNG5, CNGB2, OCNC2, OCNCb ENSG00000132259 Cyclic nucleotide gated channel alpha 4 11 6234765-6244429 Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 8 fallopian tube: 14.7;testis: 4.8 lung: 1.2 CNGB3 ACHM1, ACHM3, RMCH ENSG00000170289 Cyclic nucleotide gated channel beta 3 8 86553977-86743675 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 5 fallopian tube: 1.2;testis: 1.5 endometrium: 0.2 GALNT8 GALNAC-T8 ENSG00000130035 Polypeptide N-acetylgalactosaminyltransferase 8 12 4720341-4851927 Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA012638, HPA014418, HPA073461 Uncertain Uncertain Vesicles Tissue enhanced 0 rectum: 25.9 colon: 12.1 HCN1 BCNG-1, BCNG1, HAC-2 ENSG00000164588 Hyperpolarization activated cyclic nucleotide-gated potassium channel 1 5 45259247-45696151 Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA019195 Supportive Tissue enriched 6 cerebral cortex: 10.0 heart muscle: 1.6 HCN2 BCNG-2, BCNG2, HAC-1 ENSG00000099822 Hyperpolarization activated cyclic nucleotide-gated potassium channel 2 19 589893-617159 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 6 cerebral cortex: 15.6;heart muscle: 5.2 testis: 1.8 HCN3 KIAA1535 ENSG00000143630 Hyperpolarization activated cyclic nucleotide-gated potassium channel 3 1 155277583-155289848 Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA026584 Uncertain Mixed liver: 4.9 HCN4 ENSG00000138622 Hyperpolarization activated cyclic nucleotide-gated potassium channel 4 15 73319859-73369264 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 heart muscle: 1.2;testis: 4.0 cerebral cortex: 0.6 KCNA1 AEMK, HUK1, Kv1.1, MBK1, RBK1 ENSG00000111262 Potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia) 12 4909905-4931361 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB022365 Uncertain Tissue enriched 19 cerebral cortex: 6.9 thyroid gland: 0.3 KCNA10 Kv1.8 ENSG00000143105 Potassium voltage-gated channel, shaker-related subfamily, member 10 1 110517251-110518838 FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level No evidence Evidence at protein level HPA015061, CAB022564 Uncertain Uncertain Nucleus but not nucleoli, Cytoplasm Not detected testis: 0.4 KCNA2 HK4, Kv1.2 ENSG00000177301 Potassium voltage-gated channel, shaker-related subfamily, member 2 1 110593580-110631474 FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB001976 Uncertain Group enriched 5 cerebral cortex: 8.5;thyroid gland: 2.2 tonsil: 1.0 KCNA3 HLK3, HPCN3, Kv1.3, MK3 ENSG00000177272 Potassium voltage-gated channel, shaker-related subfamily, member 3 1 110672465-110675033 FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA016625 Uncertain Mixed lymph node: 6.7 KCNA4 HK1, HPCN2, KCNA4L, Kv1.4 ENSG00000182255 Potassium voltage-gated channel, shaker-related subfamily, member 4 11 30009741-30017023 FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB001977, HPA016422 Uncertain Tissue enhanced 0 adrenal gland: 5.1;cerebral cortex: 2.2 heart muscle: 1.1 KCNA5 HK2, HPCN1, Kv1.5 ENSG00000130037 Potassium voltage-gated channel, shaker-related subfamily, member 5 12 5043989-5046788 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA021516, CAB022562 Supportive Group enriched 5 esophagus: 4.0;heart muscle: 12.6 adipose tissue: 1.5 KCNA6 HBK2, Kv1.6, PPP1R96 ENSG00000151079 Potassium voltage-gated channel, shaker-related subfamily, member 6 12 4809176-4813412 FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level CAB011539, HPA014418 Uncertain Not detected heart muscle: 0.1 KCNA7 HAK6, Kv1.7 ENSG00000104848 Potassium voltage-gated channel, shaker-related subfamily, member 7 19 49067418-49072941 FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enriched 42 skeletal muscle: 20.1 prostate: 0.4 KCNB1 Kv2.1 ENSG00000158445 Potassium voltage-gated channel, Shab-related subfamily, member 1 20 49363877-49482647 FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB001979, HPA042434 Supportive Tissue enhanced 0 adipose tissue: 7.2;cerebral cortex: 10.8 fallopian tube: 4.7 KCNB2 Kv2.2 ENSG00000182674 Potassium voltage-gated channel, Shab-related subfamily, member 2 8 72537391-72938349 FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Tissue enhanced 0 cerebral cortex: 1.5;spleen: 1.9 fallopian tube: 0.4 KCNC1 Kv3.1 ENSG00000129159 Potassium voltage-gated channel, Shaw-related subfamily, member 1 11 17734812-17783055 FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA047634 Supportive Tissue enriched 6 cerebral cortex: 7.6 testis: 1.1 KCNC2 Kv3.2 ENSG00000166006 Potassium voltage-gated channel, Shaw-related subfamily, member 2 12 75040077-75209868 FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA019664, CAB022571 Uncertain Supportive Cytoplasm, Plasma membrane Tissue enriched 10 cerebral cortex: 19.2 prostate: 1.9 KCNC3 Kv3.3, SCA13 ENSG00000131398 Potassium voltage-gated channel, Shaw-related subfamily, member 3 19 50311937-50333515 Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level HPA018041 Uncertain Mixed fallopian tube: 9.5 KCNC4 C1orf30, HKSHIIIC, Kv3.4 ENSG00000116396 Potassium voltage-gated channel, Shaw-related subfamily, member 4 1 110211343-110283100 Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA014740 Uncertain Uncertain Nucleoli, Cytoplasm Mixed cerebral cortex: 3.5 KCND1 Kv4.1 ENSG00000102057 Potassium voltage-gated channel, Shal-related subfamily, member 1 X 48961378-48971569 FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level HPA000524, HPA001066 Uncertain Uncertain Nucleus Mixed gallbladder: 2.3 KCND2 KIAA1044, Kv4.2, RK5 ENSG00000184408 Potassium voltage-gated channel, Shal-related subfamily, member 2 7 120273668-120750331 FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA029068 Uncertain Tissue enhanced 0 cerebral cortex: 11.0 gallbladder: 3.2 KCND3 KSHIVB, Kv4.3, SCA19, SCA22 ENSG00000171385 Potassium voltage-gated channel, Shal-related subfamily, member 3 1 111770662-111989155 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA029452 Uncertain Mixed cerebral cortex: 13.7 KCNF1 IK8, KCNF, kH1, Kv5.1 ENSG00000162975 Potassium voltage-gated channel, subfamily F, member 1 2 10911937-10914225 Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level CAB004678, HPA014738 Supportive Uncertain Golgi apparatus Tissue enriched 26 cerebral cortex: 17.0 endometrium: 0.6 KCNG1 K13, KCNG, kH2, Kv6.1 ENSG00000026559 Potassium voltage-gated channel, subfamily G, member 1 20 51003656-51023129 Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA039530, HPA040024 Uncertain Supportive Vesicles Tissue enhanced 0 endometrium: 9.4 placenta: 7.1 KCNG2 KCNF2, Kv6.2 ENSG00000178342 Potassium voltage-gated channel, subfamily G, member 2 18 79863668-79900184 Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level No evidence Evidence at protein level HPA048628 Uncertain Not detected cerebral cortex: 0.1 KCNG3 Kv6.3 ENSG00000171126 Potassium voltage-gated channel, subfamily G, member 3 2 42442017-42494097 Predicted membrane proteins, Voltage-gated ion channels Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enhanced 0 adrenal gland: 0.8;cerebral cortex: 0.7 testis: 0.5 KCNG4 Kv6.4 ENSG00000168418 Potassium voltage-gated channel, subfamily G, member 4 16 84218667-84239750 Predicted membrane proteins, Voltage-gated ion channels Evidence at transcript level No evidence Evidence at transcript level HPA039161 Uncertain Not detected adrenal gland: 0.2 KCNH1 eag, eag1, h-eag, Kv10.1 ENSG00000143473 Potassium voltage-gated channel, subfamily H (eag-related), member 1 1 210678315-211134115 Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA019445 Supportive Tissue enriched 10 cerebral cortex: 5.6 adrenal gland: 0.5 KCNH2 erg1, HERG, Kv11.1, LQT2 ENSG00000055118 Potassium voltage-gated channel, subfamily H (eag-related), member 2 7 150944961-150978315 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB006838, HPA040783, HPA056584 Uncertain Tissue enhanced 0 bone marrow: 21.1;testis: 18.8 heart muscle: 7.1 KCNH3 BEC1, elk2, Kv12.2 ENSG00000135519 Potassium voltage-gated channel, subfamily H (eag-related), member 3 12 49539157-49558308 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA051088 Uncertain Group enriched 6 cerebral cortex: 10.8;fallopian tube: 4.4 testis: 1.3 KCNH4 elk1, Kv12.3 ENSG00000089558 Potassium voltage-gated channel, subfamily H (eag-related), member 4 17 42156891-42181278 Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Tissue enhanced 0 cerebral cortex: 0.7 urinary bladder: 0.3 KCNH5 eag2, H-EAG2, Kv10.2 ENSG00000140015 Potassium voltage-gated channel, subfamily H (eag-related), member 5 14 62699454-63102037 Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level HPA030487 Uncertain Uncertain Cytoskeleton (Microtubules), Microtubule organizing center Tissue enhanced 0 adrenal gland: 1.0;cerebral cortex: 1.9 testis: 0.3 KCNH6 erg2, HERG2, Kv11.2 ENSG00000173826 Potassium voltage-gated channel, subfamily H (eag-related), member 6 17 63523334-63548977 Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level CAB022674 Uncertain Tissue enhanced 0 kidney: 5.1;prostate: 2.5;small intestine: 3.4 duodenum: 1.5 KCNH7 erg3, HERG3, Kv11.3 ENSG00000184611 Potassium voltage-gated channel, subfamily H (eag-related), member 7 2 162371407-162838730 Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA018039 Uncertain Tissue enriched 6 cerebral cortex: 2.4 stomach: 0.3 KCNH8 elk3, Kv12.1 ENSG00000183960 Potassium voltage-gated channel, subfamily H (eag-related), member 8 3 19148454-19535646 Predicted membrane proteins, Voltage-gated ion channels Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enhanced 0 cerebral cortex: 2.5 adrenal gland: 1.6 KCNJ1 Kir1.1, ROMK1 ENSG00000151704 Potassium inwardly-rectifying channel, subfamily J, member 1 11 128836315-128867373 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level HPA026962 Supportive Tissue enriched 146 kidney: 108.2 skin: 0.7 KCNJ10 Kir1.2, Kir4.1 ENSG00000177807 Potassium inwardly-rectifying channel, subfamily J, member 10 1 160037467-160070248 Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 6 cerebral cortex: 61.4;kidney: 16.9 spleen: 6.9 KCNJ11 BIR, Kir6.2 ENSG00000187486 Potassium inwardly-rectifying channel, subfamily J, member 11 11 17385859-17389331 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level HPA048891 Uncertain Tissue enhanced 0 skeletal muscle: 20.5 cerebral cortex: 4.3 KCNJ12 hIRK1, IRK2, KCNJN1, Kir2.2, Kir2.2v ENSG00000184185 Potassium inwardly-rectifying channel, subfamily J, member 12 17 21376197-21419872 FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA027021 Uncertain Tissue enriched 6 skeletal muscle: 16.7 heart muscle: 2.9 KCNJ13 Kir1.4, Kir7.1, LCA16 ENSG00000115474 Potassium inwardly-rectifying channel, subfamily J, member 13 2 232766464-232776568 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enriched 12 small intestine: 82.9 thyroid gland: 7.1 KCNJ14 IRK4, Kir2.4 ENSG00000182324 Potassium inwardly-rectifying channel, subfamily J, member 14 19 48455509-48466980 Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA071765 Uncertain Nucleoli Mixed skin: 0.9 KCNJ15 IRKK, Kir1.3, Kir4.2 ENSG00000157551 Potassium inwardly-rectifying channel, subfamily J, member 15 21 38157034-38307357 Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level HPA016702 Uncertain Uncertain Plasma membrane, Cytoplasm, Vesicles Tissue enhanced 0 kidney: 143.7;thyroid gland: 100.7 lung: 28.4 KCNJ16 BIR9, Kir5.1 ENSG00000153822 Potassium inwardly-rectifying channel, subfamily J, member 16 17 70053429-70135608 Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at transcript level HPA059563 Uncertain Group enriched 7 kidney: 112.9;thyroid gland: 125.8 gallbladder: 17.8 KCNJ2 IRK1, Kir2.1, LQT7 ENSG00000123700 Potassium inwardly-rectifying channel, subfamily J, member 2 17 70168673-70180048 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level HPA029109 Uncertain Mixed fallopian tube: 6.7 KCNJ3 GIRK1, KGA, Kir3.1 ENSG00000162989 Potassium inwardly-rectifying channel, subfamily J, member 3 2 154698299-154858352 Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA024231 Uncertain Group enriched 7 cerebral cortex: 13.5;duodenum: 7.8;heart muscle: 7.3;kidney: 6.9;prostate: 3.1;small intestine: 6.9 gallbladder: 1.1 KCNJ4 HIR, hIRK2, HRK1, IRK3, Kir2.3 ENSG00000168135 Potassium inwardly-rectifying channel, subfamily J, member 4 22 38426327-38455199 Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 24 cerebral cortex: 18.2;heart muscle: 8.7 fallopian tube: 0.5 KCNJ5 CIR, GIRK4, KATP1, Kir3.4, LQT13 ENSG00000120457 Potassium inwardly-rectifying channel, subfamily J, member 5 11 128891356-128921035 Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014722, HPA017353, CAB022569 Supportive Group enriched 5 adrenal gland: 51.5;spleen: 12.6 placenta: 6.2 KCNJ6 BIR1, GIRK2, hiGIRK2, KATP2, KCNJ7, Kir3.2 ENSG00000157542 Potassium inwardly-rectifying channel, subfamily J, member 6 21 37607376-37916446 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level CAB012452 Uncertain Tissue enriched 6 cerebral cortex: 1.3 stomach: 0.2 KCNJ8 Kir6.1 ENSG00000121361 Potassium inwardly-rectifying channel, subfamily J, member 8 12 21764955-21775581 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA031066 Uncertain Uncertain Nucleus but not nucleoli, Nuclear membrane, Cytoplasm Mixed heart muscle: 20.7 KCNJ9 GIRK3, Kir3.3 ENSG00000162728 Potassium inwardly-rectifying channel, subfamily J, member 9 1 160081570-160090563 Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Tissue enriched 97 cerebral cortex: 24.6 testis: 0.2 KCNK1 DPK, K2p1.1, TWIK-1 ENSG00000135750 Potassium channel, subfamily K, member 1 1 233614004-233672512 Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA016049, CAB022588 Supportive Uncertain Vesicles Mixed stomach: 33.8 KCNK12 K2p12.1, THIK-2, THIK2 ENSG00000184261 Potassium channel, subfamily K, member 12 2 47516581-47570939 Predicted membrane proteins, Voltage-gated ion channels Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enriched 15 cerebral cortex: 2.5 tonsil: 0.1 KCNK13 K2p13.1, THIK-1, THIK1 ENSG00000152315 Potassium channel, subfamily K, member 13 14 90061765-90185857 Predicted membrane proteins, Voltage-gated ion channels Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA003514 Uncertain Uncertain Nucleus but not nucleoli, Cell Junctions Tissue enhanced 0 testis: 8.9 kidney: 3.1 KCNK15 dJ781B1.1, K2p15.1, KCNK11, KCNK14, KIAA0237, KT3.3, TASK-5, TASK5 ENSG00000124249 Potassium channel, subfamily K, member 15 20 44745780-44752313 Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level HPA064861 Uncertain Tissue enhanced 0 fallopian tube: 5.0 testis: 1.7 KCNK16 K2p16.1, TALK-1, TALK1 ENSG00000095981 Potassium channel, subfamily K, member 16 6 39314698-39322968 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA016567 Uncertain Group enriched 7 duodenum: 1.6;pancreas: 3.5;stomach: 7.7 small intestine: 0.5 KCNK17 K2p17.1, TALK-2, TALK2, TASK-4, TASK4 ENSG00000124780 Potassium channel, subfamily K, member 17 6 39299001-39314553 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA043892 Uncertain Mixed lung: 3.1 KCNK18 K2p18.1, TRESK, TRESK-2, TRESK2, TRIK ENSG00000186795 Potassium channel, subfamily K, member 18 10 117197489-117210299 Disease related genes, Potential drug targets, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level No evidence Evidence at protein level HPA044739 Uncertain Not detected adipose tissue: 0.0 KCNK2 K2p2.1, TREK-1 ENSG00000082482 Potassium channel, subfamily K, member 2 1 215005775-215237093 FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA056054 Uncertain Uncertain Cytoplasm, Mitochondria Tissue enriched 6 adrenal gland: 51.8 thyroid gland: 8.2 KCNK3 K2p3.1, TASK, TASK-1 ENSG00000171303 Potassium channel, subfamily K, member 3 2 26692690-26733420 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA026658 Uncertain Tissue enhanced 0 adrenal gland: 70.8 placenta: 18.8 KCNK4 K2p4.1, TRAAK ENSG00000182450 Potassium channel, subfamily K, member 4 11 64291302-64300031 Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enriched 7 cerebral cortex: 1.0 placenta: 0.1 KCNK5 K2p5.1, TASK-2 ENSG00000164626 Potassium channel, subfamily K, member 5 6 39188973-39229450 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA059148 Uncertain Uncertain Nucleus Mixed small intestine: 25.9 KCNK6 K2p6.1, TWIK-2 ENSG00000099337 Potassium channel, subfamily K, member 6 19 38319844-38329020 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level CAB022637, HPA040184 Uncertain Uncertain Cytoplasm, Cytoskeleton (Actin filaments) Mixed endometrium: 14.1 KCNK7 K2p7.1 ENSG00000173338 Potassium channel, subfamily K, member 7 11 65592855-65595996 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Voltage-gated ion channels Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enriched 5 skin: 34.0 esophagus: 6.3 KCNK9 K2p9.1, TASK-3, TASK3 ENSG00000169427 Potassium channel, subfamily K, member 9 8 139600838-139703056 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level HPA059318 Supportive Nucleus but not nucleoli, Plasma membrane Group enriched 9 adrenal gland: 2.4;cerebral cortex: 1.4 testis: 0.2 KCNMA1 KCa1.1, mSLO1, SLO ENSG00000156113 Potassium large conductance calcium-activated channel, subfamily M, alpha member 1 10 76869601-77638595 Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA054648, HPA057838 Uncertain Tissue enhanced 0 smooth muscle: 98.7 endometrium: 77.9 KCNN1 hSK1, KCa2.1 ENSG00000105642 Potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1 19 17951293-18000080 Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Tissue enriched 9 cerebral cortex: 9.9 testis: 1.1 KCNN2 hSK2, KCa2.2 ENSG00000080709 Potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2 5 114360945-114496640 Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA038221 Uncertain Uncertain Nucleus but not nucleoli, Cytoplasm Tissue enhanced 0 adrenal gland: 16.2;liver: 10.1 prostate: 8.3 KCNN3 hSK3, KCa2.3, SKCA3 ENSG00000143603 Potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3 1 154697455-154870280 Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA017990, HPA057127 Uncertain Uncertain Nucleus but not nucleoli Tissue enhanced 0 cerebral cortex: 13.0 fallopian tube: 6.3 KCNN4 hIKCa1, hKCa4, hSK4, KCa3.1 ENSG00000104783 Potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 19 43766533-43781257 FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA053841, HPA059622 Uncertain Uncertain Nucleus Tissue enhanced 0 salivary gland: 75.0 stomach: 28.4 KCNQ1 JLNS1, KCNA8, KCNA9, Kv7.1, KVLQT1, LQT, LQT1 ENSG00000053918 Potassium voltage-gated channel, KQT-like subfamily, member 1 11 2444684-2849109 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB018656, HPA048553 Supportive Tissue enhanced 0 adrenal gland: 84.9;thyroid gland: 79.6 stomach: 42.4 KCNQ2 BFNC, EBN, EBN1, ENB1, HNSPC, KCNA11, Kv7.2 ENSG00000075043 Potassium voltage-gated channel, KQT-like subfamily, member 2 20 63406039-63472638 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA016642, HPA057112 Uncertain Uncertain Endoplasmic reticulum Group enriched 13 adrenal gland: 5.5;cerebral cortex: 21.5;testis: 10.2 prostate: 0.9 KCNQ3 EBN2, Kv7.3 ENSG00000184156 Potassium voltage-gated channel, KQT-like subfamily, member 3 8 132120859-132480953 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enriched 11 cerebral cortex: 14.1 adrenal gland: 1.2 KCNQ4 DFNA2, Kv7.4 ENSG00000117013 Potassium voltage-gated channel, KQT-like subfamily, member 4 1 40784012-40840452 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level HPA018305 Uncertain Mixed smooth muscle: 1.3 KCNQ5 Kv7.5 ENSG00000185760 Potassium voltage-gated channel, KQT-like subfamily, member 5 6 72621792-73198851 Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level HPA016655 Uncertain Uncertain Vesicles Tissue enhanced 0 cerebral cortex: 11.4;thyroid gland: 7.9 skeletal muscle: 5.6 KCNS1 Kv9.1 ENSG00000124134 Potassium voltage-gated channel, delayed-rectifier, subfamily S, member 1 20 45092310-45101112 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enhanced 0 cerebral cortex: 4.5;gallbladder: 2.4 testis: 0.8 KCNS2 Kv9.2 ENSG00000156486 Potassium voltage-gated channel, delayed-rectifier, subfamily S, member 2 8 98427022-98432848 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA051417 Uncertain Tissue enhanced 0 cerebral cortex: 3.7 urinary bladder: 0.8 KCNS3 Kv9.3 ENSG00000170745 Potassium voltage-gated channel, delayed-rectifier, subfamily S, member 3 2 17877847-18361616 Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level HPA014864 Uncertain Uncertain Cytoplasm, Plasma membrane, Golgi apparatus Tissue enhanced 0 lung: 22.4;skeletal muscle: 22.2 placenta: 9.8 KCNT1 KCa4.1, KIAA1422 ENSG00000107147 Potassium channel, subfamily T, member 1 9 135702185-135793150 Disease related genes, Potential drug targets, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA059880 Uncertain Group enriched 5 cerebral cortex: 7.9;ovary: 2.9;skeletal muscle: 2.7;spleen: 3.8 testis: 0.8 KCNT2 KCa4.2, SLICK, SLO2.1 ENSG00000162687 Potassium channel, subfamily T, member 2 1 196225779-196609225 Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA051218 Uncertain Tissue enhanced 0 ovary: 5.4 cerebral cortex: 2.2 KCNV1 Kv8.1 ENSG00000164794 Potassium channel, subfamily V, member 1 8 109963645-109975847 Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enriched 27 cerebral cortex: 11.3 colon: 0.4 KCNV2 Kv8.2 ENSG00000168263 Potassium channel, subfamily V, member 2 9 2717502-2730037 Disease related genes, Potential drug targets, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA031131 Uncertain Tissue enriched 32 testis: 3.1 adipose tissue: 0.0 MCOLN1 ML4, MLIV, MST080, MSTP080, TRPM-L1, TRPML1 ENSG00000090674 Mucolipin 1 19 7522626-7534009 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA031763, CAB032637 Uncertain Supportive Plasma membrane, Cytoplasm Expressed in all spleen: 34.0 MCOLN2 FLJ36691, TRP-ML2, TRPML2 ENSG00000153898 Mucolipin 2 1 84925583-84997113 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at transcript level HPA019114, HPA048999 Uncertain Supportive Cytoskeleton (Intermediate filaments) Tissue enhanced 0 rectum: 12.8 tonsil: 11.1 MCOLN3 FLJ11006, TRP-ML3, TRPML3 ENSG00000055732 Mucolipin 3 1 85018082-85048499 Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA018106, HPA062137 Uncertain Uncertain Nucleoli, Cytoplasm Tissue enriched 7 adrenal gland: 38.5 endometrium: 5.4 PKD2 Pc-2, PC2, PKD4, TRPP2 ENSG00000118762 Polycystic kidney disease 2 (autosomal dominant) 4 88007668-88077777 Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB004544, HPA015794, HPA055297 Uncertain Uncertain Cytoplasm Expressed in all endometrium: 55.3 PKD2L1 PCL, PKD2L, PKDL, TRPP3 ENSG00000107593 Polycystic kidney disease 2-like 1 10 100288154-100330486 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB022621 Uncertain Tissue enhanced 0 spleen: 3.6 testis: 0.8 PKD2L2 TRPP5 ENSG00000078795 Polycystic kidney disease 2-like 2 5 137887968-137942747 Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA041903, HPA043634 Uncertain Uncertain Plasma membrane, Cytoplasm Tissue enriched 15 testis: 4.7 skeletal muscle: 0.3 SCN10A hPN3, Nav1.8, PN3, SNS ENSG00000185313 Sodium channel, voltage-gated, type X, alpha subunit 3 38696802-38794010 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level No evidence Evidence at protein level Evidence at protein level Not detected testis: 0.1 SCN11A NaN, Nav1.9, SCN12A, SNS-2 ENSG00000168356 Sodium channel, voltage-gated, type XI, alpha subunit 3 38845769-38950561 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level HPA036746, HPA036747 Uncertain Tissue enhanced 0 spleen: 3.3 placenta: 1.0 SCN1A FEB3, GEFSP2, HBSCI, NAC1, Nav1.1, SCN1, SMEI ENSG00000144285 Sodium channel, voltage-gated, type I, alpha subunit 2 165989160-166128013 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 36 cerebral cortex: 6.1;fallopian tube: 2.8;lung: 1.7 adipose tissue: 0.0 SCN2A HBSCI, HBSCII, Nav1.2, SCN2A1, SCN2A2 ENSG00000136531 Sodium channel, voltage-gated, type II, alpha subunit 2 165239402-165392308 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB022567 Supportive Tissue enriched 18 cerebral cortex: 31.4 kidney: 1.7 SCN3A Nav1.3 ENSG00000153253 Sodium channel, voltage-gated, type III, alpha subunit 2 165087522-165204067 FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA035396 Uncertain Tissue enhanced 0 cerebral cortex: 9.2 adrenal gland: 2.0 SCN4A HYKPP, HYPP, Nav1.4, SkM1 ENSG00000007314 Sodium channel, voltage-gated, type IV, alpha subunit 17 63938554-63972918 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA053992 Uncertain Uncertain Nucleus but not nucleoli, Microtubule organizing center Group enriched 12 adipose tissue: 7.9;skeletal muscle: 35.7 thyroid gland: 1.8 SCN5A CDCD2, CMD1E, CMPD2, HB1, HB2, HBBD, HH1, ICCD, IVF, LQT3, Nav1.5, PFHB1, SSS1 ENSG00000183873 Sodium channel, voltage-gated, type V, alpha subunit 3 38548057-38649673 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enriched 35 heart muscle: 22.2 endometrium: 0.6 SCN8A CerIII, MED, NaCh6, Nav1.6, PN4 ENSG00000196876 Sodium channel, voltage gated, type VIII, alpha subunit 12 51590266-51812864 Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enriched 7 cerebral cortex: 11.2 testis: 1.7 SCN9A ETHA, Nav1.7, NE-NA, NENA, PN1 ENSG00000169432 Sodium channel, voltage-gated, type IX, alpha subunit 2 166195185-166375993 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB013679, HPA061843 Uncertain Uncertain Plasma membrane, Cytoskeleton (Actin filaments) Mixed testis: 5.1 TPCN1 FLJ20612, KIAA1169, TPC1 ENSG00000186815 Two pore segment channel 1 12 113221050-113298585 Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA039757 Uncertain Expressed in all heart muscle: 28.5 TPCN2 TPC2 ENSG00000162341 Two pore segment channel 2 11 69048897-69090604 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA016561, HPA027080 Supportive Uncertain Nucleoli Expressed in all endometrium: 5.4 TRPA1 ANKTM1 ENSG00000104321 Transient receptor potential cation channel, subfamily A, member 1 8 72019917-72075617 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA026630 Uncertain Tissue enhanced 0 urinary bladder: 20.7 stomach: 7.3 TRPC1 HTRP-1 ENSG00000144935 Transient receptor potential cation channel, subfamily C, member 1 3 142724074-142807888 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB009387, HPA021130 Supportive Uncertain Vesicles Mixed ovary: 12.0 TRPC3 ENSG00000138741 Transient receptor potential cation channel, subfamily C, member 3 4 121879027-121951754 Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level HPA037969 Uncertain Tissue enhanced 0 smooth muscle: 2.3 cerebral cortex: 1.1 TRPC4 HTRP4, TRP4 ENSG00000133107 Transient receptor potential cation channel, subfamily C, member 4 13 37636636-37870425 Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 endometrium: 9.2;smooth muscle: 9.4 prostate: 4.0 TRPC5 PPP1R159 ENSG00000072315 Transient receptor potential cation channel, subfamily C, member 5 X 111774315-112082776 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 cerebral cortex: 0.9 liver: 0.2 TRPC6 FSGS2, TRP6 ENSG00000137672 Transient receptor potential cation channel, subfamily C, member 6 11 101451564-101872562 Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA045098 Uncertain Tissue enhanced 0 placenta: 12.4 lung: 10.8 TRPC7 ENSG00000069018 Transient receptor potential cation channel, subfamily C, member 7 5 136213320-136365537 Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level No evidence Evidence at protein level CAB022592, HPA031126 Uncertain Uncertain Focal Adhesions, Cytoskeleton (Actin filaments) Not detected adrenal gland: 0.2 TRPM1 CSNB1C, LTRPC1, MLSN1 ENSG00000134160 Transient receptor potential cation channel, subfamily M, member 1 15 31001061-31161273 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA014785 Uncertain Uncertain Nucleus but not nucleoli, Cytoplasm Group enriched 35 skin: 5.2;testis: 1.7 adipose tissue: 0.0 TRPM3 GON-2, KIAA1616, LTRPC3 ENSG00000083067 Transient receptor potential cation channel, subfamily M, member 3 9 70529063-71446904 Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Tissue enhanced 0 kidney: 11.0 testis: 2.9 TRPM4 FLJ20041 ENSG00000130529 Transient receptor potential cation channel, subfamily M, member 4 19 49157741-49211836 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA041169 Supportive Supportive Nucleus but not nucleoli, Plasma membrane Mixed prostate: 22.9 TRPM5 LTRPC5, MTR1 ENSG00000070985 Transient receptor potential cation channel, subfamily M, member 5 11 2404515-2423045 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA042115, HPA043315 Supportive Group enriched 5 colon: 0.6;duodenum: 1.6;small intestine: 1.4 thyroid gland: 0.2 TRPM6 CHAK2, FLJ22628, HOMG, HSH ENSG00000119121 Transient receptor potential cation channel, subfamily M, member 6 9 74722495-74888094 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA007037 Uncertain Group enriched 6 colon: 11.1;duodenum: 5.1;rectum: 13.2;small intestine: 5.9 kidney: 1.4 TRPM7 CHAK1, LTRPC7, TRP-PLIK ENSG00000092439 Transient receptor potential cation channel, subfamily M, member 7 15 50552473-50686815 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA035523, HPA052173 Uncertain Uncertain Nucleus but not nucleoli Expressed in all thyroid gland: 15.9 TRPM8 ENSG00000144481 Transient receptor potential cation channel, subfamily M, member 8 2 233917398-234019522 FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enriched 8 prostate: 93.1 liver: 11.2 TRPV1 VR1 ENSG00000262304 Transient receptor potential cation channel, subfamily V, member 1 17 3565444-3636249 Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Mixed duodenum: 5.4 TRPV4 CMT2C, OTRPC4, TRP12, VR-OAC, VRL-2, VROAC ENSG00000111199 Transient receptor potential cation channel, subfamily V, member 4 12 109783085-109833401 Disease related genes, Potential drug targets, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA007150 Uncertain Tissue enhanced 0 kidney: 12.0;salivary gland: 10.5 placenta: 6.2 TRPV5 CaT2, ECAC1 ENSG00000127412 Transient receptor potential cation channel, subfamily V, member 5 7 142908101-142933808 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level HPA063175 Uncertain Tissue enhanced 0 kidney: 0.8 testis: 0.2 TRPV6 CaT1, ECAC2 ENSG00000165125 Transient receptor potential cation channel, subfamily V, member 6 7 142871203-142885762 Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level HPA062644, HPA062864 Uncertain Uncertain Nucleus, Nucleoli Tissue enhanced 0 prostate: 24.7;salivary gland: 34.8 placenta: 18.1